AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 72 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,363,223 | -7.4% | 175,447 | +15.4% | 0.00% | 0.0% |
| Q2 2023 | $1,471,863 | -23.5% | 152,052 | -13.4% | 0.00% | -25.0% |
| Q1 2023 | $1,925,113 | +61.5% | 175,649 | -36.3% | 0.00% | +100.0% |
| Q4 2022 | $1,191,797 | -41.7% | 275,879 | +1.4% | 0.00% | -33.3% |
| Q3 2022 | $2,046,000 | +1.5% | 272,163 | +35.8% | 0.00% | +50.0% |
| Q2 2022 | $2,015,000 | -19.8% | 200,481 | -1.1% | 0.00% | +100.0% |
| Q1 2022 | $2,511,000 | -39.7% | 202,808 | +11.4% | 0.00% | -75.0% |
| Q4 2021 | $4,165,000 | -11.1% | 182,106 | -14.0% | 0.00% | +33.3% |
| Q3 2021 | $4,686,000 | +648.6% | 211,784 | +112.4% | 0.00% | +50.0% |
| Q3 2017 | $626,000 | -29.0% | 99,702 | -30.7% | 0.00% | 0.0% |
| Q2 2017 | $882,000 | -69.7% | 143,851 | -63.7% | 0.00% | -66.7% |
| Q1 2017 | $2,907,000 | +162.8% | 396,045 | -24.8% | 0.01% | +200.0% |
| Q4 2016 | $1,106,000 | – | 526,371 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |